Increased concentrations of GDF-15 were noted in cardiomyocytes during ischemia–reperfusion injury and myocardial infarction [133], in response to treatment with anthracyclines and trastuzumab in breast cancer patients [132,134]. The gene discussed is GDF15; the disease is breast cancer.